A great setup in Celldex Therapeutics (CLDX).

I want to look at Celldex ( NASDAQ:CLDX ) today. Biotech has been doing pretty well. After a little pullback so many of these high flyers have firmed up and now they’re moving higher again, some more so than others. But look at Celldex ( NASDAQ:CLDX ), now this company isn’t slated to announce earnings until sometime in March. Their last earnings were announced in early December, so just add three months and that’s pretty much when you can expect Celldex ( NASDAQ:CLDX ) to announce earnings next.

So this is really trading just technically, it’s just trading technically. Here and here a bounce out of this volatility squeeze, that’s your phase 1 breakout. Phase 2 is a pullback of unknown depth, we don’t know if the stocks going to pull back and then bounce, or if it’s just going to keep on going, and then keep on going, and keep on going. That’s what makes phase 2 a little risky. So we got a pull back to the 50-day moving average and this is firming up, and now we’re expecting this to continue to move higher. I mean, how many times have you seen a pattern like this, hopefully a whole bunch because I have, where the stocks chopping around here, big extreme move, working it off for how long? Been working it off for one, two, three, like four months this stock has been working off of this big move.

The 50-day moving average has gone from moving higher to just moving sideways, and the stock has now fallen back to that 50-day moving average, the mean, the average price over the last 50-days, and looks like it’s poised to move higher from here. So this is a stock on that I think is going to work, I think it’s going to work quite well for you. So what I’d suggest doing is get long the stock, be patient with it, it can osculate around a little bit, but I think this stock is holding up right at the 50-day moving average. Any further upside you’re probably going to see and a real nice move to new highs.